EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis

Isamu Yamakawa iD, Ryota Tamura, Hiroyuki Yabata, Takahito Tsukamoto, Shuhei Kobashi, Yoshitaka Tamaki, Nobuhiro Ogawa, Akihiro Kitamura, Makoto Urushitani iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0358772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Isamu Yamakawa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Shiga University of Medical Science, Otsu, Shiga, Japan. Hauptthemen laut MEDLINE: Carbon Dioxide, Amyotrophic Lateral Sclerosis, Sodium, Chlorides. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shiga University of Medical Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Respiratory failure is the leading cause of death in amyotrophic lateral sclerosis (ALS). Early detection of CO 2 retention is crucial for assessing respiratory failure severity and guiding noninvasive positive pressure ventilation (NPPV) management. However, arterial blood gas analysis is invasive and uncomfortable for routine monitoring.

Objective

We investigated whether the serum sodium-chloride difference (Na-Cl value), calculated from routine blood tests, could serve as a screening marker for CO 2 retention in ALS patients.

Methods

This retrospective study included 88 ALS patients with 116 paired samples of arterial blood gas and serum electrolyte data. We analyzed correlations between Na-Cl value and blood gas parameters (HCO 3 − , PCO 2 ), performed receiver operating characteristic (ROC) analysis for detecting CO 2 retention (PCO 2 ≥ 45 mmHg), and examined relationships with respiratory function (%FVC).

Results

Na-Cl value showed strong correlation with HCO 3 − (r = 0.78, p < 0.001) and PCO 2 (r = 0.71, p < 0.001). Na-Cl ≥ 37 mEq/L demonstrated sensitivity of 85.11% and specificity of 69.57% for detecting PCO 2 ≥ 45 mmHg, with negative predictive value of 87.27% (AUC = 0.842). Na-Cl ≥ 39 mEq/L achieved specificity of 92.75%. Patients with %FVC < 50% had significantly higher Na-Cl, PCO 2 , and HCO 3 − values.

Conclusions

Serum Na-Cl value serves as a simple, noninvasive screening marker for CO 2 retention in ALS. Na-Cl ≥ 37 mEq/L warrants blood gas analysis, while Na-Cl ≥ 39 mEq/L provides specificity >90%. This marker can be calculated from routine blood tests without additional cost, making it suitable for frequent monitoring and reducing the risk of missing intervention timing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbon DioxideAmyotrophic Lateral SclerosisSodiumChloridesHumansFemaleRetrospective StudiesMaleBlood Gas AnalysisMiddle AgedAgedROC CurveRespiratory InsufficiencyBiomarkersAdult

Substanzen

Carbon DioxideSodiumChloridesBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Shiga University of Medical Science, Otsu, Shiga, Japan.

ORCID-Profile: Isamu Yamakawa, Makoto Urushitani

Förderung

  • Shiga University of Medical Science

Zitieren

APA

Yamakawa, I., Tamura, R., Yabata, H., Tsukamoto, T., Kobashi, S., Tamaki, Y., Ogawa, N., Kitamura, A., & Urushitani, M. (2026). Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis. PLOS One. https://doi.org/10.1371/journal.pone.0358772

Vancouver

Yamakawa I, Tamura R, Yabata H, Tsukamoto T, Kobashi S, Tamaki Y, et al. Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis. PLOS One. 2026. doi:10.1371/journal.pone.0358772

BibTeX
@article{Yamakawa2026,
  author = {Yamakawa, Isamu and Tamura, Ryota and Yabata, Hiroyuki and Tsukamoto, Takahito and Kobashi, Shuhei and Tamaki, Yoshitaka and Ogawa, Nobuhiro and Kitamura, Akihiro and Urushitani, Makoto},
  title = {Serum Na-Cl value from routine blood tests reflects CO2 retention in amyotrophic lateral sclerosis},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0358772}
}
Kostenlos starten →